April 5, 2021

Phase 1 Clinical Trial of WRAIR-developed COVID-19 Vaccine Begins

A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter

March 5, 2021

WRAIR, Duke scientists find evidence of monoclonal antibodies’ efficacy in fighting malarial infection

Scientists at Walter Reed Army Institute of Research, in a collaboration with Duke University, have

Dec. 22, 2020

Newly Identified PTSD Biotypes Enable Improved Screening Tools, Shed Light on Divergent Efficacy of PTSD Treatments

Researchers from the PTSD Systems Biology Consortium, led by scientists from the Walter Reed Army

Dec. 18, 2020

Brain Injury Signatures Found among Healthy Persons Link to Occupational Blast Exposure

Scientists at the Walter Reed Army Institute for Research recently demonstrated that brain-related

Nov. 3, 2020

MicroRNA May Serve as Therapeutic Targets for Traumatic Brain Injury

Scientists at the Walter Reed Army Institute for Research have shown that microRNA biomarkers

Oct. 9, 2020

WRAIR Continues Its Fight against Drug-resistant Bacteria and Wound Infections

Though the COVID-19 pandemic remains a top priority for the U.S. Army and government’s healthcare